BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28971862)

  • 1. Efficacy of Ceftriaxone, Cefepime, Doxycycline, Ciprofloxacin, and Combination Therapy for Vibrio vulnificus Foodborne Septicemia.
    Trinh SA; Gavin HE; Satchell KJF
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis.
    Kim SE; Shin SU; Oh TH; Kim UJ; Darboe KS; Kang SJ; Jang HC; Jung SI; Shin HY; Park KH
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007478. PubMed ID: 31188821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vibrio vulnificus infection: a persistent threat to public health.
    Yun NR; Kim DM
    Korean J Intern Med; 2018 Nov; 33(6):1070-1078. PubMed ID: 29898575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis.
    Jang HC; Choi SM; Kim HK; Kim SE; Kang SJ; Park KH; Ryu PY; Lee TH; Kim YR; Rhee JH; Jung SI; Choy HE
    PLoS One; 2014; 9(6):e101118. PubMed ID: 24978586
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Kim SE; Kim HK; Choi SM; Yu Y; Kim UJ; Darboe KS; Kang SJ; Park KH; Kang G; Kim YR; Rhee JH; Jung SI; Jang HC
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative PCR and in vivo efficacy of antibiotics in the treatment of Vibrio vulnificus infection in a mouse model.
    Neupane GP; Kim DM; Yun NR; Shin SH; Lim SC; Choi CH
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2461-7. PubMed ID: 22434454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vibrio vulnificus meningoencephalitis in a patient with thalassemia and a splenectomy.
    He R; Zheng W; Long J; Huang Y; Liu C; Wang Q; Yan Z; Liu H; Xing L; Hu Y; Xie H
    J Neurovirol; 2019 Feb; 25(1):127-132. PubMed ID: 30397825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deferasirox plus ciprofloxacin combination therapy after rapid diagnosis of Vibrio vulnificus sepsis using real-time polymerase chain reaction.
    Kim DM; Cho HS; Kang JI; Kim HS; Park CY
    J Infect; 2008 Dec; 57(6):489-92. PubMed ID: 18930321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe septicemia, necrotizing fasciitis, and peritonitis due to Vibrio vulnificus in a patient undergoing continuous ambulatory peritoneal dialysis: a case report.
    Kim CS; Bae EH; Ma SK; Kim SW
    BMC Infect Dis; 2015 Oct; 15():422. PubMed ID: 26467000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection.
    Chiang SR; Tang HJ; Chang PC; Cheng KC; Ko WC; Chen CH; Chuang YC
    J Microbiol Immunol Infect; 2007 Apr; 40(2):123-33. PubMed ID: 17446960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vibrio vulnificus pneumonia with multiorgan failure: a case report and review of the literature.
    Abeyagunawardena I; Priyankara D
    J Med Case Rep; 2023 May; 17(1):205. PubMed ID: 37202814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus.
    Tang HJ; Chang MC; Ko WC; Huang KY; Lee CL; Chuang YC
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3580-4. PubMed ID: 12384368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro time-kill activities of ciprofloxacin alone and in combination with the iron chelator deferasirox against Vibrio vulnificus.
    Neupane GP; Kim DM
    Eur J Clin Microbiol Infect Dis; 2010 Apr; 29(4):407-10. PubMed ID: 20127132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance of Vibrio parahaemolyticus and Vibrio vulnificus in various countries: A review.
    Elmahdi S; DaSilva LV; Parveen S
    Food Microbiol; 2016 Aug; 57():128-34. PubMed ID: 27052711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificus.
    Tang HJ; Chen CC; Lai CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):76-81. PubMed ID: 27260781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vibrio vulnificus infection: diagnosis and treatment.
    Bross MH; Soch K; Morales R; Mitchell RB
    Am Fam Physician; 2007 Aug; 76(4):539-44. PubMed ID: 17853628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of severe sepsis due to Vibrio vulnificus wound infection acquired in the Baltic Sea.
    Ruppert J; Panzig B; Guertler L; Hinz P; Schwesinger G; Felix SB; Friesecke S
    Eur J Clin Microbiol Infect Dis; 2004 Dec; 23(12):912-5. PubMed ID: 15599654
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Hendren N; Sukumar S; Glazer CS
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28551603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finger Necrotizing Fasciitis and Septicemia Caused by
    Hu P; Liu G; Xu H; Su Y
    Surg Infect (Larchmt); 2024 May; 25(4):329-331. PubMed ID: 38608243
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of fatal food-borne septicemia: can family physicians provide prevention?
    Martin G; Wright AM; Banakarim K
    J Am Board Fam Pract; 2000; 13(3):197-200. PubMed ID: 10826868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.